£515.00

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

Alpha-1 Antitrypsin Deficiency Treatment Outlook in India

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 23 days · 23 data points (no recent data)

Historical
Generating forecast…
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 11 August 2026 16 August 2026 22 August 2026 27 August 2026 02 September 2026
View at Amazon ↗

Price data last checked 68 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 23 days • 1 price levels

Days at Price
23 days 0 6 12 17 23 £515 Days at Price

Price Analysis

Most common price: £515 (23 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 23 days

Description

This comprehensive study provides a detailed outlook for Alpha-1 antitrypsin deficiency treatments in India from 2023 to 2028. The report analyzes latent demand, also known as potential industry earnings (P.I.E.), across various states, union territories, and cities. With data covering over 4,900 cities, it offers a granular view of the market landscape. By providing the percent share each city holds within its state or union territory and its share of the national market, this study serves as a vital tool for professionals. The statistical approach helps in developing effective distribution and sales force strategies through comparative benchmarks.

Key Features

Covers the 2023-2028 outlook for Alpha-1 antitrypsin deficiency treatments specifically within the Indian market.

Provides latent demand estimates in millions of U.S. dollars across more than 4,900 cities in India.

Includes potential industry earnings (P.I.E.) data to help identify market opportunities.

Offers comparative benchmarks by reporting the percent share of each city relative to its state, union territory, and India as a whole.

Supports the development of strategic distribution and sales force planning through detailed statistical data.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
29 September 2022

Similar Products You Might Like

Alpha-1 Antitrypsin Deficiency Treatment Outlook in India
99% match

Alpha-1 Antitrypsin Deficiency Treatment Outlook in India

£515.00 03 Sep 2026
Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028
99% match

Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028

£520.00 02 Sep 2026
Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028
99% match

Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028

£520.00 03 Sep 2026
World Outlook: Alpha-1 Antitrypsin Deficiency Treatments
99% match

World Outlook: Alpha-1 Antitrypsin Deficiency Treatments

£790.00 28 Aug 2026
The 2026-2031 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments
99% match

The 2026-2031 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments

£885.00 27 Aug 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in China
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in China

£495.00 30 Sep 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in Japan
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in Japan

£495.00 07 Nov 2026
Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028
98% match

Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028

£490.00 24 Aug 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies for US Zip Codes
98% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies for US Zip Codes

£490.00 01 Oct 2026
Alpha-1 Antitrypsin Drug Outlook 2023-2028 US Zip Codes
98% match

Alpha-1 Antitrypsin Drug Outlook 2023-2028 US Zip Codes

£490.00 26 Aug 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
96% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
Pulmonary Fibrosis Treatment Outlook 2023-2028 - US Study
96% match

Pulmonary Fibrosis Treatment Outlook 2023-2028 - US Study

£520.00 05 Nov 2026
World Outlook for Idiopathic Pulmonary Fibrosis Treatments
96% match

World Outlook for Idiopathic Pulmonary Fibrosis Treatments

£790.00 05 Nov 2026
US Air Treatment Products Outlook 2023-2028 Study
96% match

US Air Treatment Products Outlook 2023-2028 Study

£520.00 24 Aug 2026
Anti-Inflammatory Asthma Drugs Outlook 2023-2028 Report
96% match

Anti-Inflammatory Asthma Drugs Outlook 2023-2028 Report

£520.00 03 Sep 2026
US Animal Health API Outlook 2023-2028 Report
96% match

US Animal Health API Outlook 2023-2028 Report

£520.00 03 Sep 2026
Advanced Therapy Medicinal Products Outlook India 2023-2028
96% match

Advanced Therapy Medicinal Products Outlook India 2023-2028

£515.00 06 Nov 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
96% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China

£495.00 28 Aug 2026
Asthma Treatments in India Outlook 2023-2028 Study
96% match

Asthma Treatments in India Outlook 2023-2028 Study

£515.00 02 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India

£515.00 01 Oct 2026
2023-2028 US Advanced Therapy Medicinal Products Outlook
96% match

2023-2028 US Advanced Therapy Medicinal Products Outlook

£520.00 05 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States

£520.00 02 Oct 2026
2023-2028 US Asthma Treatment Outlook - Market Study
96% match

2023-2028 US Asthma Treatment Outlook - Market Study

£520.00 06 Nov 2026